Assessing quality of life in clinical trials (CTs) - what should be paid attention to?

被引：0

作者：

Engelhardt, M. ^{[1
]}

Ihorst, G. ^{[2
]}

Waldschmidt, J. ^{[1
]}

Keller, A. ^{[1
]}

Deschler, B. ^{[3
]}

Dold, S. ^{[1
]}

Zober, A. ^{[1
]}

Messner, C. ^{[1
]}

Moeller, M. ^{[1
]}

Wuensch, A. ^{[4
]}

Wirsching, M. ^{[5
]}

Antes, G. ^{[6
]}

Vach, W. ^{[7
]}

Duyster, J. ^{[1
]}

Waesch, R. ^{[1
]}

机构：

[1] Univ Freiburg, Med Ctr, Hematol & Oncol, Comprehens Canc Ctr Freiburg CCCF, Freiburg, Germany

[2] Univ Freiburg, Clin Trials Ctr, Freiburg, Germany

[3] Univ Hosp Wurzburg, CCC Mainfranken, Dept Internal Med 2, Wurzburg, Germany

[4] Tech Univ Munich, Munich, Germany

[5] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany

[6] Univ Freiburg, Cochrane Ctr, Freiburg, Germany

[7] Univ Freiburg, Ctr Med Biometry & Med Informat, Freiburg, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V123

引用

页码：29 / 29

页数：1

共 50 条

[1] Assessing quality of life in clinical trials
Epstein, RS
EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 67 - 76
[2] Assessing quality of life in clinical trials
Fitzpatrick, Ray
PUBLIC HEALTH, 2006, 120 (07) : 682 - 682
[3] Opportunities and challenges: Assessing quality of life in clinical trials
Giesler, RB
Willinms, SD
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (20): : 1498 - 1499
[4] Assessing quality of life in clinical trials: Methods and practice
Weis, Joachim
PSYCHO-ONCOLOGY, 2007, 16 (03) : 258 - 259
[5] Reduced schedule of antenatal visits - Attention should be paid to what women
Hinshaw, K
ElHorishy, A
Bates, S
BRITISH MEDICAL JOURNAL, 1996, 313 (7050): : 168 - 168
[6] Should healthy volunteers in clinical trials be paid according to risk? No
Saunders, John
BRITISH MEDICAL JOURNAL, 2009, 339
[7] ASSESSING QUALITY-OF-LIFE IN CLINICAL-TRIALS - REPLY
HURNY, C
ANNALS OF ONCOLOGY, 1993, 4 (06) : 520 - 520
[8] Quality of life (QOL), financial burden, and perception of care in patients enrolled on clinical trials (CTs).
Sidana, Surbhi
Allmer, Cristine
Larson, Melissa C.
Dueck, Amylou C.
Yost, Kathleen J.
Warsame, Rahma M.
Thanarajasingam, Gita
Cerhan, James Robert
Paludo, Jonas
Rajkumar, S. Vincent
Habermann, Thomas Matthew
Nowakowski, Grzegorz S.
Lin, Yi
Gertz, Morie A.
Witzig, Thomas E.
Dispenzieri, Angela
Gonsalves, Wilson, I
Ansell, Stephen M.
Thompson, Carrie A.
Kumar, Shaji
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[9] What should be considered in clinical trials?
Ehlers, Alexander P. F.
Bartholomae, Julian
Becker, Carolin
ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2023, 161 (04): : 359 - 365
[10] Should healthy volunteers in clinical trials be paid according to risk? Yes
Jones, Eleri
Liddell, Kathleen
BRITISH MEDICAL JOURNAL, 2009, 339 : b4142

← 1 2 3 4 5 →